Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    "Birt-Hogg-Dube syndrome"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Topical Rapamycin for Fibrofolliculomas
Condition: Birt-Hogg-Dubé Syndrome
Interventions: Drug: Rapamycin;   Drug: placebo
2 Recruiting Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Conditions: Renal Cancer;   Chromophobe Renal Cell Carcinoma;   Birt-Hogg-Dube Syndrome
Intervention: Drug: Everolimus
3 Recruiting Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Conditions: Kidney Neoplasms;   Kidney Cancer;   Pneumothorax;   FLCN Protien, Human
Intervention:
4 Recruiting Prevalence of Spontaneous Pneumothorax in BHD
Condition: Spontaneous Pneumothorax
Interventions: Radiation: CT scan of the thorax;   Genetic: blood sample for FLCN mutation analyses

Study has passed its completion date and status has not been verified in more than two years.